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Introduction
1INTRODUCTION
Multiple Doppler echo-cardio graphic variables may be used to assess
left ventricular (LV) diastolic function.1-3 However, these variables reflect the
beat-to-beat interaction of LV filling pressures and ventricular compliance,
making them sensitive to rapid alternations in ventricular preload and
afterload.4 Because of opposing effects of preload and compliance on
transmitral velocities, the mitral inflow pattern may appear normal
(pseudonormal) despite abnormal filling pressures.1-2 Despite these limitations,
Doppler indices of diastolic function have been shown to predict morbidity and
mortality in patients with acute myocardial infarction (AMI).5-8 In particular, a
restrictive diastolic filling pattern, characterized by an abbreviated mitral E-
wave deceleration time, predicts a poor outcome.6-8
During ventricular diastole, the left atrium (LA) is directly exposed to
LV pressures through the open mitral valve. LA size is therefore largely
determined by the same factors that influence diastolic LV filling.9-10 It is,
however, a more stable indicator, reflecting the duration and severity of
diastolic dysfunction.11 Left atrial (LA) enlargement has been proposed as a
barometer of diastolic burden and a predictor of common
cardiovascular outcomes such as atrial fibrillation, stroke, congestive
heart failure, and cardiovascular death. It has been shown that advancing age
alone does not independently contribute to LA enlargement, and the impact of
gender on LA volume can largely be accounted for by the differences in body
2surface area between men and women.  Therefore,  enlargement  of  the  left
atrium reflects remodelling associated with pathophysiologic processes. For
this reason, it is hypothesized that LA volume would predict long-term
outcome after AMI and might be superior in this respect to conventional
Doppler indices of diastolic function. There is strong evidence that left atrial
(LA) enlargement, as determined by echocardiography, is a robust predictor of
cardiovascular outcomes. Recently, it has been shown that LA volume provides
a more accurate measure of LA size than conventional M-mode LA dimension
12. To optimize the use of LA volume for risk stratification, an understanding of
the physiologic determinants of LA size and the methods for accurate
quantitation is pivotal. To address this, we performed a study of patients who
had comprehensive assessment of LV systolic and diastolic function, including
assessment of LA volume, early after AMI.
Coronaryheart disease remains the number one cause of death in the
country, for both men and women. The magnitude of these age-related
conditions is expected to increase because of the burgeoning older
population. Significant progress has been made in the evaluation and
treatment of certain clinical risk factors for primary and secondary
prevention of cardiovascular diseases. The value of echocardiographic
assessment of these patients with coronary artery disease is of great value.
Patients with STEMI and NSTEMIs had progressive LA enlargement with
reductions in conduit and active emptying volumes, reflecting persistent left
3ventricular diastolic dysfunction consequent to coronary artery disease and
associated diabetes 13. The measurement of LA volumes after STEMI and
NSTEMI may be useful to monitor chronic diastolic dysfunction resulting from
ischemic burden and the severity of coronary artery disease 13.
Review of
literature
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Doppler Echocardiographic Assessment of Diastolic Function
After an AMI, myocardial ischemia, cell necrosis, microvascular
dysfunction, and regional wall motion abnormalities will influence the rate of
active relaxation. In addition, interstitial edema, fibrocellular infiltration, and
scar formation will directly affect LV chamber stiffness. Thus, abnormalities in
LV filling are common in this setting.
Spectral Pulsed-Wave Doppler Echocardiography
The pulsed-wave Doppler technique allows assessment of flow
velocities (<2 m/s) at a distinct spatial position, making the technique suitable
for assessment of changes in inflow velocities across the mitral valve during
diastole. With mitral valve opening, the early inflow velocity will be
determined largely by ventricular suction and the pressure gradient between the
LA and LV.1, 2 This is followed by a steady decrease in inflow velocity, with a
normal duration of 140 to 240 ms (early mitral deceleration time [DT]) (Figure
2). After a period of diastasis, atrial contraction will cause a new increase in
inflow velocity less than that of the early inflow; thus, the ratio of early to atrial
inflow velocities (E/A ratio) will usually be 1 to 1.5. If active relaxation is
impaired, the early mitral inflow velocity will decrease, increasing the atrial
contribution to filling, resulting in a reversal of the E/A ratio and a prolonged
DT. This "impaired relaxation" pattern, indicative of grade 1 diastolic
5dysfunction, is usually associated with normal LV filling pressure (Figure 3).
With worsening of diastolic dysfunction, LA pressure increases, and the
gradient between the LA and LV at mitral valve opening increases; hence, the
velocity of early inflow will increase even though relaxation is impaired.
Because of rapid equilibration, early ventricular filling is terminated abruptly,
causing a shortening of the time period during which early filling occurs;
hence, DT returns to normal.
Figure 1
6Therefore, the combination of delayed relaxation and elevated LA
pressure may create an apparently normal transmitral inflow pattern that has
been termed pseudonormal (grade 2 diastolic dysfunction) (Figure 1). With
further deterioration, early filling will terminate abruptly because of the
increase  in  LV  stiffness.  The  DT  will be abnormally short and the E/A ratio
will be high, a pattern termed restrictive (grade 3 diastolic dysfunction) (Figure
3). The restrictive filling pattern can be subdivided further as reversible, if
preload reduction, accomplished either by treatment or by the Valsalva
maneuver, causes reversal of the filling pattern to the nonrestrictive pattern, or
irreversible, if preload reduction causes no reversal of the filling pattern.1, 2
In patients with previous AMI, short DT (<140 ms) is associated with
elevated LV filling pressures, even in the presence of atrial fibrillation and
irrespective of the severity of mitral regurgitation. In contrast, DT >140 ms,
especially in patients with preserved LV systolic function, correlates poorly
with filling pressures. Although transmitral filling patterns are fundamental to
the assessment of LV diastolic function, they have several limitations. They
may change rapidly with variations in preload. Pseudonormalization of the
inflow pattern despite moderate elevation of filling pressures is a further major
shortcoming. To overcome this, less load-dependent indices of LV filling can
be used, usually in combination with transmitral parameters. These may include
assessment of the pulmonary venous flow pattern. This, however, is difficult to
obtain in all patients and is greatly affected by heart rhythm. Thus, other
7techniques have been developed. The most extensively validated of these are
the determination of blood flow propagation within the LV with the use of
color M-mode and tissue Doppler assessment of mitral annulus motion during
diastole.
Color M-Mode Doppler Echocardiography
The color M-mode Doppler technique, performed in the apical
4-chamber view, reflects the distribution of blood velocities along a vertical
line from the mitral plane to the apex of the LV. Color M-mode therefore
provides spatiotemporal information on the propagation of blood into the LV
(Figure 2). The slope of this early surge of blood into the LV has been termed
flow propagation velocity (Vp), which is slowed when relaxation is impaired
and, in contrast to the mitral E wave, remains reduced when LA pressure
increases.Vp is also affected by LV geometry, intraventricular pressure
gradients, and synchrony of wall relaxation.3 Several studies have demonstrated
a negative correlation between Vp and invasive measures of LV relaxation
during myocardial ischemia and during both blockade and stimulation of
ß-adrenergic receptors. Under physiological conditions, Vp has been
demonstrated to be relatively preload independent.
8Figure 2
Based on this, Vp has been used in combination with peak mitral E-wave
velocity to assess filling pressures and has proven useful in detecting a
pseudonormalized LV filling pattern. The ratio of mitral E to Vp allows
estimation of filling pressure during sinus rhythm or atrial fibrillation; E/Vp
ratio >1.5 is suggestive of increased (>15 mm Hg) pulmonary capillary wedge
pressure. Although useful in many situations, the assessment of LV filling with
flow propagation has limitations. In ventricles with severe hypertrophy, Vp may
appear normal because of enhanced intraventricular gradients despite delayed
relaxation. In addition, several different methods for acquisition and analysis of
color M-mode recordings have been used. In the majority of more recent
studies, the method proposed by Garcia et al3 has been adopted. According to
9this method, the M-mode cursor is positioned in the center of LV inflow,
avoiding boundary regions. Vp is measured as the first aliasing velocity
(45 cm/s) from the mitral annulus in early diastole to 4 cm distally into the LV
cavity. In patients with a low mitral E-wave velocity, baseline shift is adjusted
to alias at 75% of the E-wave velocity. Even when this method is used, the
interobserver  variability  may  be  as  high  as  10%  to  20%, with the greatest
variability for high (normal) values of Vp.
Spectral Pulsed-Wave Tissue Doppler Echocardiography
The motion of myocardium during the cardiac cycle can be displayed as
a spectral pulsed-wave Doppler image, in which the signal will reflect the
movement of myocardium parallel with the Doppler cursor. Because the apex
of the LV is relatively fixed throughout the cardiac cycle and the motion of the
LV base is nearly parallel with the long axis, assessment of the movement of
the basal LV segments reflects the longitudinal vector of contraction and
relaxation. Early diastolic mitral annulus velocity (e') is a useful indicator of
LV relaxation (Figure 2). Invasive studies have demonstrated that e' correlates
inversely with invasive indices of relaxation. In the presence of low (<0.1 m/s)
velocities, e' is less affected by changes in preload and may be used to identify
pseudonormal LV filling. Using the ratio of peak mitral E-wave velocity to
early mitral annulus velocity (E/e'), numerous studies have demonstrated a
good approximation of LV filling pressures. This relationship has been
validated in the presence of atrial fibrillation, sinus tachycardia, preserved or
10
depressed LV systolic function, secondary mitral regurgitation, and LV
hypertrophy. Ommen et al demonstrated that E/e' >15 accurately detects
elevated filling pressures, and E/e' <8 accurately detects normal LV filling
pressures. However, because the Doppler method tracks the velocity of
movement, tissue Doppler cannot separate active contraction from passive
tethering. Annular velocities vary depending on the location sampled, with the
velocity of the lateral annulus usually higher than that of the septal annulus.
This has led to controversy about which site should be used. Local myocardial
damage may affect the mitral annular velocity, which may be a theoretical
disadvantage of this measurement in AMI.
Tissue Doppler or Color M-Mode for Assessment of LV Filling
Although different in methodology, both tissue Doppler and color
M-mode are relatively preload insensitive, allow estimation of filling pressures
with reasonable accuracy, and facilitate identification of the pseudonormal LV
filling pattern. In patients with small LV cavities due to hypertrophy, tissue
Doppler is preferred because of pseudonormalization of Vp. Although Vp has a
good reproducibility for distinguishing normal from abnormal, the
reproducibility of e' is superior. In assessment of filling pressures and detection
of pseudonormal LV filling, most studies but not all that have compared the
techniques have favored E/e'. Thus, the better reproducibility and lesser
dependence on LV geometry make tissue Doppler echocardiography e'
measurement the preferred technique.
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LA Phasic Function and Size
The LA mechanical function can be described broadly by three phases
within the cardiac cycle14 (figure 3). First, during ventricular systole and
isovolumic relaxation, the LA functions as a "reservoir" that receives blood
from pulmonary venous return and stores energy in the form of pressure.
Second, during the early phase of ventricular diastole, the LA operates as a
"conduit" for transfer of blood into the left ventricle (LV) after mitral valve
opening via a pressure gradient, and through which blood flows passively from
the pulmonary veins into the left ventricle during LV diastasis. Third, the
"contractile" function of the LA normally serves to augment the LV stroke
volume by approximately 20%15. The relative contribution of this "booster
pump" function becomes more dominant in the setting of LV dysfunction16,17.
The size of the LA varies during the cardiac cycle18-22. Generally, only
maximum LA size is routinely measured in clinical practice. However, various
LA volumes19-22 can be used to describe LA phasic function:
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1. Maximum LA volume occurs just before mitral valve opening.
2. Minimum LA volume occurs at mitral valve closure.
3. Total  LA  emptying  volume  is  an estimate of reservoir volume,
which is calculated as the difference between maximum and
minimum LA volumes.
4. LA passive emptying volume is calculated as the difference
between maximal LA volume and the LA volume preceding atrial
contraction (at the onset of the P-wave on electrocardiography).
5. LA active emptying (contractile) volume is calculated as the
difference between pre-atrial contraction LA volume and minimum
LA volume.
6. LA (passive) conduit volume is calculated as the difference
between LV stroke volume and the total LA emptying volume.
13
Figure 3
The LA mechanical function described broadly by three phases
within the cardiac cycle and measurement of anteroposterior LA
linear dimension by M-mode echocardiography
14
The relative contribution of LA phasic function to LV filling is
dependent upon the LV diastolic properties23 and therefore varies with age19. In
subjects with normal diastolic function, the relative contribution of the
reservoir, conduit, and contractile function of the LA to the filling of the LV is
approximately 40%, 35%, and 25%, respectively23. With abnormal LV
relaxation, the relative contribution of LA reservoir and contractile function
increases and conduit function decreases. However, as LV filling pressure
progressively increases with advancing diastolic dysfunction, the LA serves
predominantly as a conduit23.
Assessment of LA Size and Function
Two-dimensional and Doppler methods have been used increasingly for
the assessment of LA size and function, respectively.
LA size assessment. Measurement of anteroposterior LA linear
dimension by M-mode echocardiography24-25 (Figure 3) is simple and
convenient but not reliably accurate, given that the LA is not a symmetrically
shaped three-dimensional (3D) structure26. Furthermore, because LA
enlargement may not occur in a uniform fashion27, one-dimensional assessment
is likely to be an insensitive assessment of any change in LA size. In contrast to
LA dimension, LA volume by two-dimensional (2D) or 3D echocardiography
provides a more accurate and reproducible estimate of LA size, when compared
with reference standards such as magnetic resonance imaging (MRI) and cine
computerized tomography (CT)28-31, and has a stronger association with
cardiovascular outcomes13,32,33. Accordingly, the American Society of
Echocardiography has recommended quantification of LA size by biplane 2D
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echocardiography using either the method of discs (by Simpson’s rule) or the
area-length method14 (Figure 4). Although we have routinely used the area-
length method in our laboratory, we have found that the biplane Simpson’s
method is comparable in accuracy and reproducibility. Critical elements and
common pitfalls for accurate and reproducible measurement of biplane LA
volume assessment are detailed and outlined in Table 1. The Biplane area
length method requires measuring LA area from two orthogonal apical views
(A1 and A2) and LA length (L), from which LA volume is calculated as (0.85
x A1 x A2)/L ( Figure 4). When LA length is measured from two apical views,
the shorter value is used to calculate LA volume.
Echocardiographic methods systematically underestimate LA volume
when compared with CT34 or MRI quantitation30, which in turn underestimates
true LA size22. More recently, magnetic electroanatomic mapping has also been
used for assessment of LA volume35. However, because of its portability and
safety, echocardiographic assessment of LA volume is preferable to other
imaging methods in clinical practice.
LA volume reference limits. Reference values for 2D
Echocardiographic maximum LA volumes have been estimated using data
collected on persons free of cardiovascular disease, although few samples have
been population based32,36. Published reference values for maximum and
minimum LA volumes are 22 ± 6 ml/m2 (37) and 9 ± 4 ml/m2 (38), respectively. In
a  study  of  LA  function,  mean  total  LA emptying volume was
13.5 ± 4.3 ml/m2 (representing 37 ± 13% of LV stroke volume), fractional
emptying of the LA was 65 ± 9%, and conduit volume was 23 ± 8 ml/m2 (39).
16
Figure  4
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Table 1 Critical elements and common pitfalls for accurate and
reproducible measurement of biplane area- length method LA volume
assessment
Step
Common
Limitations/Errors
Suggestions
A. Optimize LA
image quality
Atria are located in the far
field of the apical views.
Reduction of lateral
resolution may result in
apparently thicker LA
walls.
Not improved by modifying the gain
settings: Increase in gain will further
reduce LA lumen size.Decrease in
gain may lead to image "drop out" and
difficulties in planimetry of LA area.
Use high resolution sample box to
increase pixel density and facilitate
accurate tracing of the endocardial
border. Capture at least five beats for
each cine loop to maximize likelihood
of obtaining adequate image quality.
B. Obtain maximal
LA size
LA is foreshortened Modify transducer angulation or
location (place the transducer one
intercostal space lower) until LA
image is optimized and not
foreshortened. If discrepancy in the
two lengths measured from the
orthogonal planes is >5 mm,
acquisition should be repeated until
the discrepancy is reduced.
C. Timing of
maximum LA
size
Correct frame for
measurement is not
selected
Choose frame just before mitral valve
opening
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Step
Common
Limitations/Errors
Suggestions
D. LA area
planimetry
LA border is
inconsistently defined
Consistently adhere to convention:
Inferior LA border—plane of mitral
annulus (not the tip of leaflets).
Exclude atrial appendage and
confluences of pulmonary veins
E. Long-axis LA
length
LA long axis is
inconsistently delineated
Consistently adhere to convention:
Inferior margin—midpoint of mitral
annulus plane. Superior (posterior)
margin—midpoint of posterior LA
wall
F. Interpretation Qualitative categorization
of LA size
LA volume indexed to BSA is
optimally interpreted as a continuous
variable (using a reference point of 22
± 5 ml/m2 as "normal")
Assessment of LA functions by echocardiography. Pulsed-wave
Doppler evaluation of transmitral and pulmonary venous blood flow velocity
can be used for assessment of LA function, in addition to its widespread use for
the evaluation of LV diastolic function and filling pressure40-42. The normal
pulmonary venous flow pattern reflects flow from the pulmonary veins to the
LA during early ventricular systole (PVs1; seen distinctly in about 30% of
transthoracic echocardiography studies43), late ventricular systole and
isovolumic relaxation (PVs2), early ventricular diastole (PVd), and reversal of
flow from the left atrium to pulmonary veins during atrial systole (PVar).
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Apart from flow in late ventricular systole (reflected by PVs2), which
represents propagation of the right ventricular pressure pulse through the
pulmonary circulation44, blood flow in the pulmonary veins is determined by
events that regulate phasic LA pressure45. The magnitude and velocity-time
integral of the PVs waves reflect LA reservoir function and are determined by
LV systolic function and LA relaxation (PVs1), LA compliance (PVs1 and PVs2),
and right ventricular stroke volume (PVs2)44. Peak velocity and velocity-time
integral of PVd is an index of LA conduit function46 and is dependent on factors
that influence LA afterload: LV relaxation and early filling23 and mechanical
obstruction from the mitral valve apparatus47. During LA contraction, blood is
ejected from the LA into the LV and the pulmonary veins. Thus, assessment of
transmitral (peak A-wave velocity, A-wave velocity-time integral, and atrial
filling fraction)17,48 and pulmonary venous blood flow (PVar)49 provides
additive information for the evaluation of LA booster pump function.
More recently, global and regional atrial contractile function has been
evaluated with pulse wave and color tissue Doppler imaging 19, but the
incremental clinical utility of this assessment remains to be determined.
Further, new echocardiographic techniques, such as with automated border
detection using acoustic quantification, are being developed to facilitate
evaluation of LA size and function19.
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Determinants of LA Size and Remodeling
Demographic and anthropometric influences: Body size is a major
determinant of LA size. To adjust for this influence, LA size should be indexed
to a measure of body size, most commonly to body surface area32,36. It remains
to be clarified if this approach attenuates obesity-related variations in LA
volume, which may be prognostically significant50. Gender differences in LA
size are nearly completely accounted for by variation in body size19,32,51,52. In
persons free of cardiovascular disease, indexed LA volume is independent of
age from childhood onward53. Indeed, age-related LA enlargement is  a
reflection of the pathophysiologic perturbations that often accompany
advancing age rather than a consequence of chronologic aging20. The relation of
LA size to race or ethnicity has not been sufficiently studied.
Atrial structural remodelling: Many conditions are associated with
LA remodelling and dilatation. The atria will enlarge in response to two broad
conditions: pressure and volume overload. The relationship between increased
LA size and increased filling pressures has been validated against invasive
measures in subjects with54,55 and without41,56 mitral valve disease. Left atrial
enlargement due to pressure overload  is  usually  secondary  to  increased  LA
afterload, in the setting of mitral valve disease or LV dysfunction. Case reports
have suggested that LA dilatation can also occur in response to pressure
overload resulting from fibrosis and/or calcification of the LA. This condition,
known  as  "stiff  LA syndrome"57,58, causes a reduction of LA compliance, a
21
marked increase in LA and pulmonary pressures, and right heart failure.
Chronic volume overload associated with conditions such as valvular
regurgitation, arteriovenous fistulas, and high output states including chronic
anemia and athletic heart59,60 can also contribute to generalized chamber
enlargement. Both volume and pressure overload can increase atrial size.
However, pressure overload is uniformly accompanied by abnormal myocyte
relaxation, while volume overload is characteristically associated with normal
myocardial relaxation physiology.
LA  volume  as  an  expression  of  LV  filling  pressures. In subjects
without primary atrial pathology or congenital heart or mitral valve disease,
increased LA volume usually reflects elevated ventricular filling pressures.
During ventricular diastole, the LA is exposed to the pressures of the LV. With
increased stiffness or noncompliance of the LV, LA pressure rises to maintain
adequate LV filling61, and the increased atrial wall tension leads to chamber
dilatation and stretch of the atrial myocardium. Thus, LA volume increases
with severity of diastolic dysfunction33,62. The structural changes of the LA
may express the chronicity of exposure to abnormal filling pressures33,56 and
provide predictive information beyond that of diastolic function grade63, which
is determined from evaluating multiple load-dependent parameters and
therefore reflective of the instantaneous LV diastolic function and filling
pressures. In this way, analogous to the relationship between hemoglobin A1C
and random glucose levels, LA volume reflects an average effect of LV filling
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pressures over time, rather than an instantaneous measurement at the time of
study64. Thus, Doppler and tissue Doppler assessment of instantaneous filling
pressure is better suited for monitoring hemodynamic status in the short term,
whereas LA volume is useful for monitoring long-term hemodynamic control.
Left atrial size as an expression of diastolic function and filling pressures
has not been fully evaluated in specific conditions. Most studies of LA size and
outcomes have excluded patients with atrial fibrillation (AF). The relationship
between AF and LA volume is complex65. It has been difficult to establish the
causal relationship between AF and LA structural remodeling. In patients with
AF and cardiac disease, structural LA alterations may  be  related  to  the
underlying cardiac pathophysiology rather than solely the arrhythmia itself66, 67.
Experimental animal studies have documented that sustained atrial
tachyarrhythmias induce electrical, contractile and structural remodeling68. In
some  cases,  it  appears  that  LA  structural  remodeling  may be related to high
ventricular rate and increased ventricular filling pressures rather than to the
atrial tachyarrhythmia itself69,70.  However,  in  other  individuals,  the  size  of  the
LA varies widely for given LV relaxation and filling properties, suggesting a
hysteresis between LA sizes and filling pressures. Few studies have assessed
the impact of sustained AF on atrial structure in patients with lone AF71.
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LA Volume as a Marker of Diastolic Dysfunction
The LA acts as a conduit between the pulmonary vascular bed and the
LV, receiving blood from the pulmonary veins and conveying it to the LV
through passive and active filling. In addition, the atrium acts as an efficient
volume sensor, releasing natriuretic peptides and other neurohormones to the
circulation as a consequence of increased atrial wall stress. After opening of the
mitral valve, the LA and LV diastolic pressures will rapidly equalize, and
emptying of the LA will be determined largely by LV filling dynamics.72,73
Thus, when the LA empties against a noncompliant LV  and/or  there  is  an
increase in LV end-diastolic pressure, LA  pressure  will  rise.  This  is  poorly
tolerated by the thin wall of the LA, and subsequent dilation will occur.73
Chronic LA pressure overload will cause reduced myocardial energy
production, alterations in contractile proteins, and myocyte atrophy, which
eventually will cause LA wall fibrosis. Thus, with chronic distension there is
little elastic recoil in the LA, and a chronically enlarged atrium will be
relatively unaffected by transient changes in LA pressure.73,74 Because of this
relative insensitivity to transient changes in filling pressures, LA size can be
considered a biomarker of sustained elevations in LV filling pressures.
With the use of echocardiography, LA size has traditionally been
estimated with M-mode measurements obtained in the parasternal long-axis
view, reflecting the anteroposterior dimension of the LA. However, the LA
does not dilate symmetrically because of physical restraint.75 Thus, with
24
expansion of the LA, the anteroposterior dimension by M-mode will
underestimate the true volume.75 With the use of planimetry performed in the
apical window, the LA volume may be assessed by either single or biplane
methods, with high reproducibility and good correlation with volumetric
assessment with the use of magnetic resonance and 3D-cine computed
ventriculography.76-78 Compared with magnetic resonance, echocardiographic
measurement of LA volume results in a slight underestimation.79 This is less
important when echocardiographic reference ranges are used. These are indexed
to the body surface area of the patients, and the normal upper limit (mean +2
SD) of echocardiographically determined LA volume index has been
determined to be 32 mL/m2.80
Relation between LA Size and Prognosis after AMI
Two recent studies have investigated the relation between LA dilatation
and all-cause mortality after AMI.85,92 In a retrospective design including 314
patients, an increase >32 mL/m2 in LA volume index was associated with a
high all-cause mortality rate. In multivariate analysis, LA volume, Killip class,
and a restrictive transmitral filling pattern were independent predictors of death,
whereas LVEF or wall motion score index did not provide any additional
prognostic information. A striking finding was that among patients with LVEF
<40%, the LA appeared normal in size in one third of patients (27 of 82). One
death occurred in this group as opposed to 22 deaths among 55 patients with
LVEF <40% and LA enlargement. In addition, the prognostic importance of
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LA volume was unrelated to the presence and severity of mitral regurgitation
and atrial fibrillation. This finding has subsequently been confirmed by Beinart
et al85 in a prospective study of 395 patients with AMI in which multivariate
analysis also identified restrictive filling, Killip class, and LA volume as
independent predictors of adverse outcome.
Why Do Patients With Abnormal LV Filling/Enlarged LA Have a Poor
Prognosis?
Consistently, irrespective of the method of assessment, it is evident that
if there are direct or indirect signs of increased LV filling pressures, the risk of
death is increased. Although the prevalence and severity of filling abnormalities
are associated with the severity of systolic dysfunction, a considerable
proportion of patients present with Doppler signs of elevated filling pressures
despite only mildly reduced LVEF. The reason why these patients poorly
tolerate what appears to be a relatively small myocardial injury is incompletely
understood. These patients are older and more likely have a history of
hypertension and diabetes compared with patients with no signs of elevated
filling pressures. They also have evidence of more generalized overt
atherosclerotic disease. The progression of cardiovascular disease can be
regarded as a continuum of events in which the presence of risk factors such as
hypertension, diabetes, and dyslipidemia predisposes to the development of
atherosclerosis, LV hypertrophy, and eventually overt coronary artery disease
and cardiac failure.102 LA volume has been shown to correlate positively with
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age and clinical cardiovascular risk score and negatively with LVEF.80 We
speculate that patients with increased LV filling pressures immediately after
AMI have an increased burden of risk and poorly tolerate an acute loss of even
relatively small amounts of myocardium. This is supported by the fact that a
considerable number of patients, even when evaluated during the first 24 hours
of AMI, present with LA enlargement. Based on the physiology of the LA, it
would not be anticipated that acute elevation of filling pressures within hours
can cause LA dilatation. This suggests that even before AMI, some patients had
abnormal LV filling and possibly abnormalities in chamber stiffness and active
relaxation with subsequent poor adaptation to the hemodynamic changes during
acute myocardial ischemia.
LV pressure overload will cause myocyte stretch, increased wall stress,
poorer subendocardial perfusion, and reduced energy production. These in turn
are associated with neurohormonal activation and ventricular remodeling.
Although the remodeling process will initially restore stroke volume and
systemic hemodynamics, continuing dilation will have a detrimental effect on
long-term LV function and survival. Previous studies of unselected patients
with AMI,91,103,104 patients with preserved systolic function,105 and patients with
ST-segment elevation AMI treated with fibrinolysis84 or successful primary
angioplasty106 have demonstrated that a restrictive filling pattern in the early
postinfarction phase predicts LV remodeling, defined as a dilatation (>20%) of
the LV end-diastolic volume. This provides an important link to long-term
prognosis.
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LA Size for the Prediction of Cardiovascular Outcomes
There is considerable data confirming the relationship between increased
LA size, principally maximal but also minimal 41,109, and the development of
adverse cardiovascular outcomes in subjects without a history of AF or
significant valvular disease.110-123
AF: Atrial fibrillation is the most common of the serious cardiac
arrhythmias and is associated with increased morbidity and mortality in the
community. Prospective data from the large population-based studies have
established a relationship between M-mode anteroposterior LA diameter and
the risk of developing AF.124,125 In the Framingham study, a 5-mm incremental
increase in anteroposterior LA diameter was associated with a 39% increased
risk for subsequent development of AF.124 In the Cardiovascular Health Study,
subjects in sinus rhythm with an anteroposterior LA diameter >5.0 cm had
approximately four times the risk of developing AF during the subsequent
period of surveillance.125 More recently, LA volume has been shown to predict
AF in patients with cardiomyopathy116,117 and first-diagnosed nonvalvular AF
in a random sample of elderly Olmsted County residents who had undergone
investigation with a clinically indicated echocardiogram.110,111 The relationship
between LA volume and LA dimension was nonlinear,116 and it has been
confirmed that LA volume represented a superior measure over LA diameter
for predicting outcomes including AF110,116,123 and provided prognostic
information that was incremental to clinical risk factors.110
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Stroke: Stroke is the leading cause of severe long-term disability and
the third largest contributor to mortality in the U.S.126 Despite the strong
association between AF and ischemic stroke, 85% of strokes occur in patients
who are in apparent sinus rhythm.126 In the general population, LA size has
been determined to be a predictor of stroke and death.127 Increased LA volume
has also been shown to predict the onset of first stroke in clinic-based elderly
persons who were in sinus rhythm and did not have a history of ischemic
neurologic events, AF, or valvular heart disease.118 Even after censoring for the
development of documented AF, an indexed LA volume 32 ml/m2 was
associated with an increased stroke risk (hazard ratio [HR] 1.67, 95%
confidence interval [CI] 1.08 to 2.58) over 4.3 ± 2.7 years, independent of age
and other clinical risk factors for cerebrovascular disease.
Heart failure: As previously discussed, LA volume is a barometer of
LV filling pressure and reflects the burden of diastolic dysfunction in subjects
without AF or significant valvular disease33. Elevation of filling pressure is
uniformly found in the presence of symptomatic congestive heart failure
(CHF). Because the majority of individuals in the community with LV
dysfunction (systolic or "isolated" diastolic) are in a preclinical phase of the
disease,128 methods to quantify the risk of progression to symptomatic heart
failure would be clinically useful. Evidence for a prognostic role for LA volume
to predict incident CHF is emerging.121,122 In  a large prospective, population-
based study, subjects with incident CHF during follow-up had slightly higher
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baseline LA linear diameters (39 mm vs. 37 mm for women [p < 0.01], 41 mm
vs. 39  mm  for  men  [p  <  0.01]).129 In  a  study  of  older  adults referred for
echocardiography, LA volume 32 ml/m2 was associated with increased
incidence of CHF, independent of age, myocardial infarction, diabetes mellitus,
hypertension, LV hypertrophy, and mitral inflow velocities (HR 1.97, 95% CI
1.4 to 2.7).121 Furthermore, in subjects with an LV ejection fraction 50% at
baseline and within four weeks of incident CHF, there was an increase of 8
ml/m2 in LA volume from baseline to CHF diagnosis, reflecting the added
burden of diastolic dysfunction during the period of transition from preclinical
to clinical status.
Mortality: The relationship between LA size and death has been
demonstrated in high-risk groups, such as patients with dilated
cardiomyopathy,112 LV dysfunction,130 atrial arrhythmias,131 acute myocardial
infarction,114,119 and patients undergoing valve replacement for aortic stenosis132
and mitral regurgitation133. The LA diameter has also been shown to
independently predict death in the general population129. However, in other
population-based studies, the relationship between LA size and death has been
attenuated when LV mass127, LV hypertrophy134, or diastolic function62 has
been considered. Thus, owing to the intimate relationship between LA volume,
LV mass/hypertrophy, and diastolic dysfunction, the incremental value of each
parameter for the prediction of death is diminished when considering the
others.
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Although a dilated LA is associated with a number of adverse outcomes,
there is increasing evidence suggesting that LA size is potentially modifiable
with medical therapy,135-144 but whether LA size reduction translates to
improved outcomes remains to be established.
Correlation of LA Size with the of severity of coronary artery disease
Patients with STEMI and NSTEMIs had progressive LA enlargement
with reductions in conduit and active emptying volumes, reflecting persistent
left ventricular diastolic dysfunction consequent to coronary artery disease and
associated diabetes. The measurement of LA volumes after STEMI and
NSTEMI may be useful to monitor chronic diastolic dysfunction resulting from
ischemic burden13 and the severity of coronary artery disease13.
LA maximum volume was significantly larger at baseline in patients
with NSTEMIs. At 12 months, maximum LA volume increased (27.6 ± 7.4 vs
30.2 ± 8.9 mL/m2, P = .002), with LA remodeling present in 64% of the
patients with NSTEMIs. LA passive emptying volume increased, with
concurrent reductions in conduit and active emptying volumes. Although
diabetes, major coronary artery disease,  and a larger myocardial score were
predictive of LA remodelling, E? velocity was the only independent predictor13.
How to Treat Abnormal LV Filling
A major unresolved question is how to manage optimally patients with
abnormal LV filling especially if LVEF is normal or only mildly reduced. To
date, no interventional trial has been undertaken with hard end points in which
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patient selection has been based on abnormalities in LV filling. However,
assessment of the inflow pattern and E/e' ratio may provide important
information on the hemodynamic status and guide the use of vasodilators and
diuretics. In addition, previous randomized data have demonstrated that
attenuation of the renin-angiotensin-aldosterone system with captopril in
patients with mildly to moderately depressed LVEF after AMI is associated
with a major improvement in central hemodynamics (LV end-diastolic and
pulmonary artery pressure), whereas the improvement in LVEF is modest.108
Likewise, small studies have demonstrated improvements in LV filling on
intervention with ß-blockers after AMI, which was associated with improved
exercise capacity.108 However, although this reduction in LV filling pressure
would be anticipated to improve functional status, it is not known whether this
is associated with a better outcome.
Conclusions
Left atrial enlargement carries important clinical and prognostic
implications. Left atrial volume is superior to LA diameter as a measure of LA
size, and should be incorporated into routine clinical evaluation. Future studies
are warranted to further our understanding of the natural history of LA
remodelling, the extent of reversibility of LA enlargement with medical
therapy, and the impact of such changes on outcomes. The utility of LA volume
and function for monitoring cardiovascular risk and for guiding therapy is an
evolving science and may prove to have a very important public health impact.
Aim of the study
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AIM OF THE STUDY
1. To evaluate the role of left atrial volume index as a predictor of
In- hospital events in patients with acute myocardial infarction by two
Dimensional echocardiography and Doppler.
2. To assess the role of LA volume index as a prognostic tool, incremental
to the standard Echocardiographic predictors of outcome, including LV
systolic function (EF) and Doppler assessment of diastolic function.
Materials and
methods
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MATERIALS AND METHODS
1)  Patient Selection:
This study was carried out in the period of February 2010 to February
2011 in the department of cardiology, Govt. Stanley Medical College Hospital,
Chennai.
110 consecutive Patients presenting to ICCU with First episode of Acute
myocardial Infarction (STEMI) were enrolled in this study after Excluding
Patients based on Exclusion Criteria. The Diagnosis of Myocardial Infarction
was based on following 3 criteria.
1. Typical chest pain
2. ECG changes suggestive of STEMI
3. Elevated cardiac enzymes
Exclusion criteria
The following groups of Patients were excluded from the study
? Patients with previous history of myocardial infarction
? Unstable angina / NSTEMI
? Previous history of Left ventricular dysfunction
? Previous history of Percutaneous coronary intervention
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? Previous history of coronary artery bypass graft
? Previous history of valve diseases or arrhythmias such as atrial
fibrillation.
? Cardiomyopathies
? Pericardial diseases
2) Ethical issues:
Since this study involve investigations, blood tests, certain life saving
interventions, medications which could alter the outcome, all patients and their
relatives were briefed about the study design at the time of enrollment. Contact
details were established for further communication as and when necessary.
3)  Study design
This is prospective observational study of all Newly diagnosed First
episode of acute myocardial infarction Patients.
4) Data collection
Following Information was obtained at the time of Admission
1. Detailed history recording
2. Thorough physical examination
3. Blood samples for relevant blood investigations
4. Serial ECG’s and complete Echocardiogram was done for all
patients.
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5)  Echocardiography:
Echocardiography was performed on a median of 1 day (range 0 to 4
days) after admission using Aloka SSD 4000 Phased Array System equipped
with Tissue Doppler and Harmonic Imaging technology.
The Biplane area- length method was used which requires  measuring
LA area from two orthogonal apical views (A1 and A2) and LA length (L),
from which LA volume is calculated as (0.85 x A1 x A2)/L ( Figure 4). When
LA length is measured from two apical views, the shorter value is used to
calculate LA volume.
The normal value of indexed LA volume has been reported to be 20±6
mL/m2.148 Patients were therefore divided according to the mean value plus 2
SDs, corresponding to 32 mL/m2.
LV systolic function was assessed semiquantitatively with a visually
estimated ejection fraction and wall-motion score index. Excellent agreement
between subjective interpretation of ejection fraction and volumetric assessment
(95% limits of agreement -6% to 7%), with low interobserver variability (95%
limits of agreement -5% to 10%) 145 has been established in previous studies.145
Each of 16 LV segments was assigned a score (1 to 5) based on myocardial
thickening.146 A wall-motion score index was calculated by dividing the sum of
scores by the number of segments visualized. Mitral regurgitation was graded
with color flow imaging.
APICAL 4 CHAMBER VIEW
APICAL 2 CHAMBER VIEW
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Mitral inflow was assessed with pulsed-wave Doppler echocardiography
from the apical 4-chamber view. The Doppler beam was aligned parallel to the
direction of flow, and a 1- to 2-mm sample volume was placed between the tips
of mitral leaflets during diastole.147 From the mitral inflow profile, the E- and
A-wave velocity and E/A velocity ratio were measured. Doppler tissue imaging
of the mitral annulus was also obtained. From the apical 4-chamber view, a 1-
to 2-mm sample volume was placed in the septal mitral annulus.
Diastolic filling was categorized as normal (grade 0), impaired
relaxation (grade 1), or restrictive (grade 3) by a combination of transmitral
flow patterns. LA volume was assessed by the biplane area-length method from
apical 4- and 2-chamber views.11 Measurements were obtained in end systole
from the frame preceding mitral valve opening, and the volume was indexed for
body surface area.
6)  In hospital complications
? Death,
? Re-MI,
? Arrhythmias,
? LV Dysfunction
? Mechanical Complication: VSR / MR
Complete patient characteristics, treatment details, Thrombolysis,
Inotropic Therapy were included in the Proforma for further analysis.
Patients with acute myocardial infarction who had undergone
thrombolysis were alone included in this study.
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7)  Analysis of the Results
The complete data collected during the study period was compiled,
analyzed and interpreted keeping the objectives in mind.
8)  Statistical Analysis
The  data  are  expressed  as  Mean  ±  SD  for  quantitative  data.  For
qualitative data are expressed as frequency and percentage. The probability
value  less  than  0.05  was  considered  significant  by  using  SPSS  software
(V.16.0). Pearson chi square test was used to compare LA volume index with
all the parameters including In-hospital events.
Results and
analysis
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RESULTS AND ANALYSIS
Results
110 Consecutive patients admitted in our ICCU with First episode of
Acute Myocardial Infarction were included in our study. Among 110 Patients
80 (72.72%) were males with the mean age of 53 ? 11 Yrs and 30 (27.27%)
were Female with the mean age of 61 ? 10 Yrs. AWMI was more common
(66.36%) than  IWMI  (33.63%)
I. Basic characteristics
1. Sex  (Table 1 & Figure. 1)
Table 1
Male 80 72.72%
Female 30 27.27%
Total 110 100%
2. Age (Table 2 )
Table 2
Sex Age (Mean ? SD) Yrs
Male 53 ? 11 Yrs
Female 61 ?  10  Yrs
3. Diagnosis (Table 3 & Figure. 2)
Table 3
AWMI 73 66.36%
IWMI 37 33.63%
Total 110 100%
SEX
72.72%
27.27%
sex
male
female
Figure. 1
DIAGNOSIS
66.36%
33.63%
Diagnosis
AWMI
IWMI
Figure.  2
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4. Risk Factors  (Table 4 & Figure. 3)
1. Smokers – 39.09%
2. Hypertension - 44.54%
3. Diabetes – 43.63%
4. Dyslipidemia – 53.63%
5. Obesity - 14.54%
Table 4
Smoking
Yes 43 39.09%
No 67 60.90%
Hypertension
Yes 49 44.54%
No 61 55.45%
Diabetes
Yes 48 43.63%
No 62 56.36%
Dyslipidemia
Yes 59 53.63%
No 51 46.36%
Obesity
Yes 16 14.54%
No 94 85.45%
Risk Factors
0
10
20
30
40
50
60
70
80
90
smoking hypertension DM dyslipidemia obesity
yes
no
39.09%
60.9%
44.54%
55.45%
43.63%
56.36% 53.63%
46.36%
14.54%
85.45%
Figure. 3
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5.  Killip Class (Table 5 & Figure. 4)
Killip Class I – 42.72%
Killip Class II -  36.36%
Killip Class III – 20.90%
Killip Class IV – 0%
Table 5
Kilip Class I II III IV Total
No. of Patients 47 40 23 0 110
Percent 42.72% 36.36% 20.90% 0% 100%
6.  Inotropic Support (Table 6 & Figure. 5)
31 Patients (28.18%) required inotrophic support
Table 6
Yes 31 28.18%
No 79 71.81%
Total 110 100%
KILLIP Class
42.72%
36.36%
20.90%
0%
No. of patients
I
II
III
IV
Figure. 4
Inotropic Support
28.18%
71.81%
No. of patients
yes
no
Figure. 5
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II.  ECHO Characteristics
7.  Diastolic Dysfunction (Table 7 & Figure. 6)
Normal – 19.09%
Grade I – 40.90%
Grade II – 30.90%
Grade III  - 9.09%
Grade IV – Nil
Table 7
Normal Grade I Grade II Grade III Total
21 45 34 10 110
19.09% 40.90% 30.90% 9.09% 100%
8. LA Volume Index  (Table 8 Figure. 7)
72 Patients (65.45%) had LA Volume Index < 32 ml / m2 and 38
Patients (34.54%) had LA Volume Index > 32 ml / m2
Table 8
< 32 ml / m2 72 65.45%
> 32 ml / m2 38 34.54%
Total 110 100%
DIASTOLIC DYSFUNCTION
19.09%
40.90%
30.90%
9.09%
No. of patients
normal
I
II
III
Figure. 6
LA Volume Index
65.45%
34.54%
No. of patients
< 32
>32
Figure. 7
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III.  IN HOSPITAL EVENTS  (Table 9 & Figure. 8)
Death – 8.18%
Re – MI – 10%
Arrhythmias – 35.45%
LV dysfunction – 75.45%
Mechanical Complications – 7.3%
Table 9
Death
Yes 9 8.18%
No 101 91.81%
Re MI
Yes 11 10%
No 99 90%
Arrhythmia
Yes 39 35.45%
No 71 64.54%
LV dysfunction
Yes 83 75.45%
No 27 24.54%
Mechanical
Complications
MR 6 5.5%
VSR 2 1.8%
No 102 92.7%
In Hospital Events
8.18% 10%
35.45%
75.45%
7.30%
91.81% 90%
64.54%
24.54%
92.70%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
100.00%
death RE MI arrythmia LV dysfunction mechanical
complications
yes
no
Figure. 8
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DATA ANALYSIS
1. Gender  and  LA Volume Index  (Table no 10 and Figure 9)
In our study, the overall patient population is predominantly male but no
statistical significance was noted.
Table 10: Gender and LAVI
LAVI Male Female Total P Value
z 57(79.16%) 15(20.83%) 72(100%)
0.0626
(Corrected)
>32 ml/m2 23(60.52%) 15(39.47%) 38(100%)
Total 80(72.72%) 30(27.27%) 110(100%)
2. Age  and  LA Volume Index  (Table no 11 and Figure. 10)
             In our study, age group of 40 – 60 years are more compared to age
group above 60 years, hence no statistical significance was noted.
Table 11: Age and LAVI
LAVI <40yrs 40-60yrs >60yrs Total p Value
<32ml/m2 5(6.94%) 41(56.94%) 26(36.11%) 72(100%)
0.6281>32ml/m2 3(7.89%) 18(47.36%) 17(44.73%) 38(100%)
Total 8(7.27%) 59(53.63%) 43(39.09%) 110(100%)
GENDER AND LAVI
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80.00%
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Figure. 9
AGE AND LAVI
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Figure. 10
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3. Diagnosis and LA Volume Index  (Table no 12 and Figure. 11)
Anterior wall myocardial infarction were more common than inferior
wall myocardial infarction in LA Volume Index >32 ml/m2 but  not enough for
a statistical significance
Table 12: Diagnosis and LAVI
LAVI AWMI IWMI Total
p
Value
<32ml/m2 48(66.66%) 24(33.33%) 72(100%)
0.9058
(Corrected)
>32ml/m2 25(65.78%) 13(34.2%) 38(100%)
Total 73(66.36%) 37(33.63%) 110(100%)
4. Smoking and LA Volume Index (Table no 13 and Figure. 12 )
Smokers were more common (65.78%) in larger LA volume index
group than smaller LA volume index group (25%) with  statistically significant
p value noted.
Table 13: Smoking and LAVI
LAVI Smoker Non smoker Total P Value
<32 ml/m2 18(25%) 54(75%) 72(100%)
0.0001
(Corrected)
>32 ml/m2 25(65.78%) 13(34.21%) 38(100%)
Total 43(39.09%) 67(60.90%) 110(100%)
DIAGNOSIS AND LAVI
0.00%
10.00%
20.00%
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Figure.11
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5. Hypertension and LA Volume Index (Table no 14 and Figure. 13 )
Hypertension was more common (73.68%) in larger LA Volume Index
group than in small LA Volume Index group (29.16%)  resulting in statistically
significant p value (0.0000).
Table 14: SHT  and LAVI
LAVI Hypertensive
Not known
Hypertensive
Total P Value
<32 ml/m2 21(29.16%) 51(70.83%) 72(100%)
0.0000
(Corrected)
>32 ml/m2 28(73.68%) 10(26.31%) 38(100%)
Total 49(44.54%) 61(55.45%) 110(100%)
6. Diabetes and  LA Volume Index (Table no 15 and Figure.  14 )
More diabetic patients in  larger LA Volume Index group(73.68%)  than
smaller lA volume index group (27.77%) resulting in a statistically significant
p value (0.0000).
Table 15: Diabetes and LAVI
LAVI Diabetics Non Diabetics Total pValue
<32 ml/m2 20(27.77%) 52(72.22%) 72(100%)
0.0000
(Corrected)
>32 ml/m2 28(73.68%) 10(26.31%) 38(100%)
Total 48(43.63%) 62(56.36%) 110(100%)
HYPERTENSION AND LAVI
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7. Dyslipidemia and LA Volume Index (Table no 16 and Figure. 15 )
Patients with larger LA Volume Index group has more  dyslipidemic
patients(86.84%)than smaller LA volume index group(36.11%) , resulting in
statistically significant p value (0.000).
Table 16: Dyslipidemia and LAVI
LAVI Present Absent Total p Value
<32 ml/m2 26(36.11%) 46(63.88%) 72(100%)
0.0000
(Corrected)
>32 ml/m2 33(86.84%) 5(13.15%) 38(100%)
Total 59(53.63%) 51(46.36%) 110(100%)
8. Obesity and LA Volume Index (Table no 17 and Figure. 16  )
Obese patients are less in our study group (14.54%) and they are also
less common among larger LA Volume Index group (13.15%). Hence no
statistical significance was noted.
Table 17: Obesity and LAVI
LAVI Present Absent Total P Value
<32 ml/m2 11(15.27%) 61(84.72%) 72(100%)
1
(Corrected)
>32 ml/m2 5(13.15%) 33(86.84%) 38(100%)
Total 16(14.54%) 94(85.45%) 110(100%)
DYSLIPIDEMIA AND LAVI
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9. Killip Class and LA Volume Index (Table no 18 and Figure. 17 )
Patients with  larger LA volume Index group had more no of patients in
Killip class II (52.63%) and Killip Class III (36.84%)   in comparison to
smaller LA Volume Index group which had more no of patients in killip class I
(59.72%). This resulted in statistically significant p value (0.0000).
Table 18: Killip Classification and LAVI
LAVI Class 1 Class 2 Class 3 Class 4 Total p Value
<32
ml/m2 43(59.72%) 20(27.77%) 9(12.5%) 0 72(100%)
0.0000
>32
ml/m2 4(10.52%) 20(52.63%) 14(36.84%) 0 38(100%)
Total 47(42.72%) 40(36.36%) 23(20.90%) 0 110(100%)
10. Inotropic support and LA Volume Index
(Table no 19 and Figure. 18)
More patients required inotropic support (42.10%)  in larger LA Volume
Index group compared to less number of patients (20.83%) requiring inotropic
support in smaller LA Volume Index group, resulting in statistically significant
p value (0.0327).
Table 19: Inotropic Support and LAVI
LAVI YES NO Total
P
 Value
<32 ml/m2 15(20.83%) 57(79.16%) 72(100%) 0.0327
>32 ml/m2 16(42.10%) 22(57.89%) 38(100%)
Total 31(28.18%) 79(71.81%) 110(100%)
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11. Re MI and LA Volume Index (Table no 20 and Figure. 19 )
Re MI occurred in 26.31% of patients in larger LA Volume Index group
compared to 1.38% in smaller LA Volume Index group resulting in statistically
significant p value (0.0001).
Table 20: Re MI  and LAVI
LAVI YES NO Total p  Value
<32 ml/m2 1(1.38%) 71(98.61%) 72(100%)
0.0001>32 ml/m2 10(26.31%) 28(73.68%) 38(100%)
Total 11(10%) 99(90%) 110(100%)
12.  Arrhythmia and LA Volume Index (Table no 21 and Figure. 20 )
Recurrent arrhythmia occurred in 68.42% of patients in larger LA
Volume Index group compared to 18.05%  in smaller LA Volume Index group
.This resulted in a statistically significant p value (0.0000).
Table 21: Arrhythmia and  LAVI
LAVI YES NO Total P Value
<32 ml/m2 13(18.05%) 59(81.94%) 72(100%)
0.0000>32 ml/m2 26(68.42%) 12(31.57%) 38(100%)
Total 39(35.45%) 71(64.54%) 110(100%)
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13.   LV Systolic Dysfunction and LA Volume Index (Table no 22 and
       Figure. 21)
       In patients with large LA volume index group, 89.47% of patients had LV
systolic dysfunction compared to 68.05% with smaller LA volume index group.
This resulted in statistically significant p value (0.0245).
Table 22: LV Systolic Dysfunction  and  LAVI
LAVI YES NO Total p Value
<32 ml/m2 49(68.05%) 23(31.94%) 72(100%)
0.0245>32 ml/m2 34(89.47%) 4(10.52%) 38(100%)
Total 83(75.45%) 27(24.54%) 110(100%)
14.  Mechanical complication and LA volume Index(Table no 23 and
     Figure. 22)
Mechanical complications were more common among larger LA volume
index group but the number is very less. Hence no statistically significant
p value.
 Table 23: Mechanical Complication and LAVI
LAVI MR VSR NO Total P Value
<32
ml/m2
2(2.77%) 0(0%)% 70(97.22%) 72(100%)
Not
significant
>32
ml/m2
4(10.52%) 2(5.26%) 32(84.21%) 38(100%)
Total 6(5.5%) 2(1.8%) 102(92.7%) 110(100%)
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15.  Death and LA Volume Index (Table No 24 and Figure. 23)
Death was more common in larger LA volume index group (21.05%)
compared to small LA Volume Index (1.38%)  This resulted in statistically
significant p value (0.0013).
Table 24: Death  and LAVI
LAVI YES NO Total P Value
<32 ml/m2 1(1.38%) 71(98.61%) 72(100%)
0.0013>32 ml/m2 8(21.05%) 30(78.94%) 38(100%)
Total 9(8.18%) 101(91.81%) 110(100%)
16. Diastolic dysfunction and LA Volume Index (Table no 25 and
Figure. 24 )
Grade II (50%) and Grade III (21.05%) diastolic dysfunction were more
common in larger LA volume index group but normal (25%) and Grade I
(51.38%)  diastolic dysfunction were more common in smaller LA volume
index group.  This resulted in statistically significant p value (0.0000).
Table 25: Diastolic Dysfunction  and LAVI
LAVI Normal Grade I Grade II Grade III Total P Value
<32
ml/m2
18(25%) 37(51.38%) 15(20.83%) 2(2.77%) 72(100%)
0.0000>32
ml/m2
3(7.89%) 8(21.05%) 19(50%) 8(21.05%) 38(100%)
Total 21(19.09%) 45(40.90%) 34(30.90%) 10(9.09%) 110(100%)
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17.   E/e’  and LA volume Index (Table no 26 and Figure. 25)
In patients with larger LA volume index group, 26.31% of patients were
having E/e’ of more than 15 compare to only 2.77% of patients was having
E/e’of more than 15 in smaller LA volume index group. This resulted in
statistically significant  p value (0.0004).
Table 26:  E/e' and LA Volume Index
LAVI <15 >= 15 Total
p
Value
<32 ml/m2 70(97.22%) 2(2.77%) 72(100%)
0.0004>32 ml/m2 28(73.68%) 10(26.31%) 38(100%)
Total 98(89.09%) 12(10.90%) 110(100%)
In patients with larger LA Volume Index group, mean E/e’ was 12.39
compared to mean E/e’ of 8.52 in smaller LA Volume Index group.
LAVI E/e'
<32 ml/m2 8.52 ±2.91
>32 ml/m2 12.39 ± 3.62
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18. LV EF and  LA Volume Index (Table no 27 and figure. 26)
More number of patients with LV EF less than 40% (57.89%) were in
larger lA volume index group compare to Less Number  (27.77%) of patients
with LV EF less than 40% were  in smaller LA volume index group.This
resulted in significant p value (0.0020).
Table 27:LV EF and LAVI
LAVI >= 40% <40% Total P Value
<32 ml/m2 52(72.22%) 20(27.77%) 72(100%)
0.0020>32 ml/m2 16(42.10%) 22(57.89%) 38(100%)
Total 68(61.81%) 42(38.18%) 110(100%)
In patients with larger LA Volume Index  group, the mean LV EF was
37.66% compared to mean LV  EF of 43.56% in small LA Volume Index
group.
LAVI EF%
<32 ml/m2 43.56  ± 8.36%
>32 ml/m2 37.66 ± 7.47%
LVEF AND LAVI
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19.  WMSI and LA Volume Index(Table no 28 and Figure. 27)
In patients with larger LA Volume Index group, 92.10% of patients had
WMSI of > 1.3 compared to 52.77% of patients in smaller LA Volume Index
group. This resulted in statistically significant p value (0.0001).
Table 28: WMSI  and LAVI
LAVI <1.3 >= 1.3 Total P Value
<32 ml/m2 34(47.22%) 38(52.77%) 72(100%)
0.0001>32 ml/m2 3(7.89%) 35(92.10%) 38(100%)
Total 37(33.63%) 73(66.36%) 110(100%)
In patients with larger LA Volume index group, mean WMSI was 1.49
compared to mean WMSI of 1.34 in smaller LA volume index group.
LAVI WMSI
<32 ml/m2 1.3410 ± 0.1547
>32 ml/m2 1.4942 ± 0.1788
WMSI AND LAVI
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DISCUSSION
This study has been conducted to demonstrate that LA volume index is a
predictor of In-hospital events after Acute Myocardial Infarction (STEMI).
Furthermore, LA volume index provides prognostic information incremental to
clinical data and standard echocardiographic predictors of outcome, including
LV systolic function, Doppler assessment of diastolic function.
LA volume index, on comparison with various clinical characteristics
1.  Gender and LA volume index, (Table No. 10 & Figure. 9)
? In our study population of 110 Patients, 72.72% were males and
27.27% were females. Males were more in number, both in LA
volume index > 32 ml/m2 and < 32 ml/m2 categories.
? Gender differences in LA Volume index does not occur as per
reviewed literature19, 32, 51, 52. Similarly in this study also there were
no significant gender bias in LA Volume index analysis
(p value 0.0626).
2.  Age Group and LA volume index, (Table No. 11 and Figure. 10)
? There exists a direct correlation between advancing age and
increased LA Volume Index i.e. Old age (< 60 years) is associated
with physiologically increased LA volume index . So inclusion of
older age patients in a study population alters the variables.
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? Age group In this study were divided in to 3 categories  i.e.
< 40 yrs, 40 to 60 yrs & > 60 yrs.
? In this study, patients > 60 yrs were less number (p < 0.625), thus
enabling a balanced study.
3.  Location of MI and LA volume index, (Table No. 12 and
Figure. No. 11)
? No independent correlation exists between regional location of MI
and magnitude of LA volume index. Similarly in this study also,
though anterior wall MI was more common, in the total study
population, as well as in the 2 categories of LA volume index, there
was no statistically significant difference (p < 0.905).
4.  Smoking and LA volume index  (Table No. 13 & Figure. No. 12)
? In the article by Teresa S M Sang MD et al 153 Left atrial volume
was found to correlate positively with age, history of systemic
hypertension, diabetes mellitus, hyperlipidemia, and smoking.
? Smokers were more common among patients with LA volume
index > 32 ml/m2 (65.78%), than LA volume index < 32 ml/m2
(25%) resulting in a  significant p value  (0.0001).
? In this study smokers had a higher incidence of increased LA
volume index (> 32ml/m2) indicating significant cardiovascular
risk.
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5.  Hypertension and LA volume index (Table No. 14 &
Figure. 13)
? Hypertension was more common among patients with LA volume
index > 32 ml/m2 (73.68%) but only 29.16% in the group of
patients with LA volume index < 32 ml/m2. As a result the p value
was significant (0.000).
? In a study of older adults referred for echocardiography, LA
volume 32 ml/m2 was associated with increased incidence of
CHF, independent of age, myocardial infarction, diabetes mellitus,
hypertension, LV hypertrophy, and mitral inflow velocities 121.
? In the article by Teresa S M Sang MD et al 153 LA volume was
found to correlate positively with cardiovascular risk score which
includes hypertension.
6.  Diabètes and  LA volume index (Table No. 15 and Figure. No. 14)
? In our study, 73.68% of patients were diabetic among patients with
LA volume > 32 ml/m2 and only 27.77% were diabetic in the group
with LA < 32 ml/m2 giving rise to a significant p value (0.000)121.
? This is similar to the study by Teresa S M Sang MD et al 153 where
LA volume was found to correlate positively with Diabetes
mellitus and other parameters of cardiovascular risk score.
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7.  Dyslipidemia and LA volume index (Table No. 16 & Figure. No. 15)
? The number of patients with dyslipidemia among LA volume index
> 32 ml/m2 was 86.84% and 36.11% among LA volume index < 32
ml/m2. The p value was  significant (0.000).
? LA volume was found to correlate positively with cardiovascular risk
score based on age, gender, history of systemic hypertension, diabetes
mellitus, hyperlipidemia, and smoking 153.  In our study the total study
population with dyslipidemia was 53.63% with a significant P value
8.  Obesity and LA volume index (Table No. 17 and Figure No. 16)
? 14.54% of Patients in this study population were obese. Of these
only 13.15% had a larger LA volume index (> 32 ml/m2), and
15.27% of obese patients had smaller LA volume index
(< 32 ml / m2) hence the p value  was not significant (1.0).
? Body size is a major determinant of LA size. To adjust for this
influence, LA size should be indexed to a measure of body size,
most commonly to body surface area32, 36. It remains to be clarified
if this approach attenuates obesity-related variations in LA volume,
which may be prognostically significant50.
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LA volume index, on comparison with In-hospital
management and events
9.  Killip Class and LA volume index (Table No. 18 & Figure No. 17)
? In this study those with killip class 2 and 3 had a larger LA volume
index (> 32 ml m2) with a statistically significant p value (0.000).
? Moller JE, Hillis GS et al 92 in their study also has proven that
Killip class was higher in patients with larger LA volume and killip
class is a predictor of increasing LA volume with disease
progression.
? Beinart et al85 in a prospective study of 395 patients with AMI
multivariate analysis identified 3 parameters i.e. restrictive filling,
killip class, and LA volume as independent predictors of adverse
outcome.
10. Inotropic support and LA volume index (Table No. 19 &
         Figure. No. 18)
? The number of patients who required inotropic support was higher
(42.10%) in the group of LA volume > 32 ml/m2 resulting in a
significant p value (0.0327).
? Moller JE, Hillis GS et al 92 in their study have demonstrated that
patients with LV dysfunction in the larger LA volume index group
needed Inotropic support.
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11.  Re-MI and LA volume index (Table No. 20 & Figure No. 19)
? Re-MI occurred more commonly in the LA volume index
>  32 ml/m2 which was 26.31% while it was only 1.38% in the LA
volume index < 32 ml/m2 group resulting in a significant p value
(0.0001).
? Moller JE, Hillis GS et al 92 have suggested in their study that most
patients with multivessel and severe disease resulted in increased
In-hospital Re – MI.
12.  Arrhythmia and LA volume index (Table No. 21 & Figure No. 20)
? Arrhythmia were more common, (68.42%) in those with LA index
volume > 32 ml/m2 group compared to 18.05% in LA volume
index <32 ml/m2,  resulting in a significant p value (0.000).
? The relationship between LA size and death has been demonstrated
in high-risk groups, such as patients with atrial arrhythmias131. LA
volume has been shown to predict AF in patients with
cardiomyopathy (Tani T, Tanabe K, Ono M, et al). Further the
relationship between LA volume and LA dimension was non
linear116,117, and it has been confirmed that LA volume represented
a superior measure over LA diameter for predicting outcomes
including AF110,116,123 and provided prognostic information that was
incremental to clinical risk factors110.
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? LA structural remodelling in some cases, may be related to higher
ventricular rate and increased ventricular filling pressures rather
than to the atrial tachyarrhythmia itself.69, 70
13. LV dysfunction  and LA volume index (Table No. 22 & Figure No. 21)
? The number of patients who had LV dysfunction among LA
volume index > 32 ml/m2 is 89.47% which is much higher than
among LA volume index < 32 ml/m2 which was only 68.05%
resulting in a significant p value (0.0245).
? LA volume 32 ml/m2 was associated with increased incidence of
CHF, independent of age, myocardial infarction, diabetes mellitus,
hypertension, LV hypertrophy, and mitral inflow velocities.121 LV
dysfunction is more common with larger LA volumes.92
14.  Mechanical complication and  LA volume index (Table No. 23  &
         Figure No. 22)
? Mechanical complication which included moderate MR and VSR,
was more common among LA volume index > 32 ml/m2. The
p value was 0.124 which is not significant since the number of
subjects under these categories were less (7.3%).
? LA volume index was greater in patients with moderate or severe
mitral regurgitation, (Moller JE, Hillis GS et al.92)
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15.  Death and LA volume index (Table No. 24 Figure No. 23)
? More deaths (21.05%) occurred in those with LA volume index
> 32 ml/m2, resulting in significant p value (0.0013).
? Relationship between LA size and death has been demonstrated in
high-risk groups, such as patients with acute myocardial infarction
114,119. More importantly LA diameter has also been shown to
independently predict death in the general population 129.
? Two recent studies have investigated the relation between LA
dilatation and all-cause mortality after AMI.85,92 In a retrospective
design including 314 patients, an increased LA volume index (> 32
ml/m2) was associated with a higher all-cause mortality rate. LA
volume index was a predictor of mortality after AMI, even after
adjustment for conventional indices of systolic and diastolic
function.92
ECHO Characteristics and LA volume index
16.  Diastolic function and LA volume index (Table No. 25 &
Figure No. 24)
? Proportion of subjects in Grade 2 and 3 diastolic dysfunction were
50% and 21.05% respectively in LA volume index > 32 ml/m2
while it was only 20.83% and 2.77% in LA volume index < 32
ml/m2. The p value was significant (0.0000).
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? Greenberg B, Chatterjee K et al have suggested that with increased
stiffness or non-compliance of the LV, LA pressure rises to
maintain adequate LV filling61, and the increased atrial wall tension
leads to chamber dilatation and stretch of the atrial myocardium.
? Tsang TS, Barnes ME et al have established that, LA volume
increases with severity of diastolic dysfunction. Furthermore LA
volume is a barometer of LV filling pressure and reflects the
burden of diastolic dysfunction in subjects without AF or
significant valvular disease33
17.  E/e’ ratio  and LA volume index (Table No. 26 & Figure No. 25)
? In this study, higher E/e’ ratio (> 15) was found in patients with
larger LA volume index (> 32 ml/m2) than those with smaller LA
volume index (< 32 ml/m2) with significant p value (0.0004).
? LA volume index was found to correlate positively with tissue
Doppler E/e? based on the study by Teresa S M Sang MD et al.153
Among patients in whom Doppler tissue imaging was performed, a
modest correlation was found between the E/e' ratio and LA
volume index.92
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18.  LVEF, and WMSI and LA volume index (Table No. 27, 28 &
         Figure 26, 27)
? In patients with LA volume index > 32 ml/m2, the LVEF was lower
(<40%) and WMSI (> 1.3%) was higher when compared with LA
volume index < 32 ml/m2, with a significant P value (0.0020 and
0.0001 respectively).
? LA volume was found to correlate positively with the grade of
diastolic function, and negatively with LV ejection fraction in the
study by Teresa S M Sang MD et al 153.In this study also patients
with EF<40%, had more cardiac events in the group with larger LA
volume index (>32 ml/m2) than with smaller LA volume index
(<32 ml/m2) as in above study. . Moller JE, Hillis GS et al 92
proved that there is a positive correlation with the wall motion
score index (WMSI) and LA volume index >32 ml/m2 .
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Study Limitations
? This study was a single center study
? Sample size was small.
? Entry criterion for this study was measurement of LA volume index.
This may have introduced a selection bias. Although it appears unlikely
that this could have affected the observed results, it may reduce their
applicability to a more general population.
? Patients with previous history of myocardial infarction were excluded
but subclinical coronary artery disease which was undiagnosed could
have changed the diastolic function of the heart.
? Our study cannot assess the predictive value of late LA remodelling and
subsequent morbidity, mortality as no long term follow up is available.
? LA is a complicated three-dimensional structure and the geometric
algorithm used only estimates its volume. Hence Real time 3 D Imaging
(RT – 3DE) may be a more accurate method of assessing LA volume
and function.
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? Doppler assessment may have resulted in the misclassification of
diastolic function in a few cases, highlighting the limitations of such
measurements. In particular, some patients with normal Doppler
parameters had LA enlargement and vice versa. Assessment of mitral
annulus motion appears to be particularly useful for assessment of
diastolic function. Unlike other Doppler parameters of diastolic function,
it appears to be relatively independent of preload and recently. It has
been shown to be the most accurate non-invasive predictor of elevated
LV filling pressure. However, the role of Doppler tissue imaging in the
prediction of outcome after AMI remains to be defined.
Conclusion
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CONCLUSION
1. The present study demonstrates that LA enlargement implies a poor
prognosis in patients with AMI. It has proved as a predictor of In-
hospital events in patients with acute myocardial infarction.
2. LA Volume index provides prognostic information incremental to
clinical data and standard Echocardiographic predictors of outcome.
Including LV systolic function and Doppler assessment of Diastolic
Function.
3. Measurement of LA volume is simple and important tool which can be
easily done and reproducible and may be incorporated in routine
assessment of diastolic function.
4. Measurement of LA volume index could emerge as a simple and
important tool for Risk stratification and as a guide for future
surveillance and therapy in patients with Acute  myocardial infarction if
confirmed by perspective studies.
5. The utility of LA volume and function for monitoring cardiovascular
risk and for guiding therapy is an evolving science and may prove to
have a very important public health impact.
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APPENDIX I
ABBREVIATIONS
2D -  Two Dimensional
3D - Three Dimensional
AF - Atrial Fibrillation
AMI - Acute Myocardial Infarction
AWMI - Anterior Wall Myocardial Infarction
BMI - Body Mass Index
BP - Blood Pressure
BSA - Body Surface Area
CABG - Coronary Artery By-Pass Graft
CAD - Coronary Artery Disease
CAG - Coronary Angiogram
CHF - Congestive Heart Failure
CI - Confidence Interval
CPK - Creatinine Phospho Kinase
CT - Computed Tomography
CVS - Cardio Vascular System
DT - Deceleration Time
DVD - Double Vessel Disease
HR - Hazard Ratio
HT - Height
IABP - Intra Aortic Balloon Pump
IWMI - Inferior Wall Myocardial Infarction
LA - Left Atrium
LAVI - LA Volume Index
LV - Left Ventricle
LVEDD  - Left Ventricular End Diastolic Dimension
LVEF - Left Ventricular Ejection Fraction
LVESD - Left Ventricular End Systolic Dimension
MR - Mitral Regurgitation
MRI - Magnetic Resonance Imaging
PCI - Percutaneous Coronary Intervention
PR - Pulse Rate
RS - Respiratory System
SVD - Single Vessel Disease
TDI - Tissue Doppler Imaging
TVD - Triple Vessel Disease
VP - Flow Velocity Propagation
VPC - Ventricular Pre-Mature Complex
VSR - Ventricular Septal Rupture
WMSI - Wall Motion Score Index
WT - Weight
APPENDIX II
PROFORMA
Name: Age:
Sex: Occupation:
Address:
Presenting Complaints:
Diagnosis: AWMI
IWMI
Risk Factors: Male Gender:
Smoker:
Hypertension:
Diabetes:
Obesity:
Hyperlipidemia:
Family History of CAD:
In Hospital Therapy: Thrombolysis:
Inotropic Therapy:
On Examination:
HT: WT: BMI: BSA:
PR: BP:
CVS: RS:
Killip Class On Admission:
Investigations:
Complete Blood Count:
Urea: Creatinine:
Electrolytes: Lipids:
CPK/MB:
ECG:
Chest X-Ray PA View:
ECHO:
LVEF, %:
LVESD, mm:
LVEDD, mm:
WMSI:
Diastolic Function:
Ratio E/e’:
LA Dimension, mm:
LA Volume, mL:
LA Volume index, mL/m2:
MR:
In Hospital Events:
Death:
Re-MI:
Arrhythmias:
LV Dysfunction:
Mechanical Complication: VSR / MR
APPENDIX  - III
MASTER CHART
S.
No.
NAME AGE SEX Diagnosis smoker SHT DM obesity dyslipidemia
family
history
thrombolysis inotropic Height Weight BSA BMI
1 thanaraj 60 M AWMI + + + - - + + - 168 65 1.7 23.04
2 venkatesan 45 M AWMI + - - - - - + - 160 60 1.6 23.43
z3 Shankar 28 M AWMI + - - - + - + - 166 74 1.8 26.9
4 Jayapal 55 M IWMI + - - - + - + - 177 92 2 29
5 Sundari 36 F IWMI -  - - - - + + - 173 64 1.6 21.4
6 srinivasan 42 M AWMI  - - + - + - + - 160 60 1.6 23.4
7 murugesan 48 M AWMI + - - - - - + - 150 50 1.4 22.2
8 rajangam 70 M AWMI - + - + - - + + 170 85 1.95 29.8
9 radhakrishanan 63 M AWMI + + + -  + - + + 163 65 1.7 24.5
10 appas hussain 57 M IWMI   + - + - + - + + 162 52 1.5 19.8
11 krishanan 50 M AWMI -  - - - - - + + 156 56 1.5 23
12 krishanan 52 M AWMI - -  - - - - + - 169 69 1.75 24.2
13 loganathan 53 M AWMI - + - - + - + - 165 65 1.65 23.8
14 Chandra 60 F AWMI  + + + + + - + + 151 79 1.75 34.6
15 abdul agis 64 M AWMI + -  + - - - + - 176 72 1.85 23.3
16 balaraman 58 M IWMI + +  - - - - + + 170 72 1.8 24.9
17 Santosh 50 M AWMI  -  - + - + - + - 155 68 1.7 25
18 Rikiram 55 M AWMI  -  - - - - - + - 163 65 1.7 24.52
19 armugam 55 M AWMI  - - + - - - + + 173 79 1.9 26.42
20 md. Basha 48 M IWMI  - - - + - - + + 170 90 1.95 31.14
21 Azhagu 46 M IWMI + - - -  - + + + 176 65 1.75 21.03
22 pappamal 60 F IWMI  - - + - + - + - 172 75 1.85 25.95
23 kanchana 68 F IWMI - + + - + - + + 155 65 1.65 27.08
24 Robert 68 M AWMI  + + + - + - + + 155 63 1.65 26.75
25 Stephan 51 M IWMI - + + - - - + - 173 57 1.7 19.06
26 Murugesan 62 M IWMI + + - + - - + - 152 70 1.65 30.3
S.
No.
NAME AGE SEX Diagnosis smoker SHT DM obesity dyslipidemia
family
history
thrombolysis inotropic Height Weight BSA BMI
27 Palani 47 M AWMI + +  - - + - + - 175 85 2 28.33
28 kashinathan 66 M AWMI + -  + +  - - + - 151 54 1.5 23.68
29 dhandapni 70 M AWMI  + + + -  + - + + 150 60 1.5 26.54
30 neelavati 73 F AWMI - + - - - - + - 176 72 1.85 23.3
31 Mastahn 57 M AWMI + +  - - - - + - 159 65 1.65 25.79
32 Erumal 70 M AWMI - - - - + - + - 165 65 1.65 23.89
33 vermuthu 45 M IWMI - -  - - + + + - 155 65 1.54 27.08
34 kothanapani 82 M AWMI  + + + -  + - + + 155 65 1.54 27.08
35 james 39 M AWMI  +  - + -  + - + + 150 60 1.5 26.54
36 chandra 60 F AWMI  - - - - + - + - 171 65 1.71 22.03
37 ismail 38 M AWMI  - - - - + - + + 177 65 1.75 22.03
38 shahulameed 74 M IWMI - - + - + - + - 159 72 1.7 28.57
39 raji 50 M IWMI  - - - - - - + + 161 72 1.75 24.91
40 arokyraj 52 M AWMI +  + + - + - + - 162 75 1.8 28.62
41 syed abulla 48 M IWMI  - -  - - + - + - 166 74 1.8 26.9
42 shanmugam 50 M IWMI + + + - + - + - 162 52 1.5 19.84
43 selvaraj 60 M IWMI  - - - + - - + - 170 63 1.7 21.79
44 kamala 70 F AWMI -  + + + + - + + 165 75 1.8 27.57
45 xavier 67 M IWMI  - - + - - + + - 177 92 2 29.39
46 radhammal 55 F AWMI - + - - + - + + 170 65 1.7 21.03
47 ramu 40 M AWMI  - - - + + - + - 170 85 1.95 32.81
48 rengraj 32 M AWMI  - - - - + - + - 170 76 1.91 29.41
49 muthu 46 M AWMI  + - - - + - + + 150 49 1.54 21.8
50 anthony 53 M IWMI  - - - -  - - + + 173 64 1.6 21.4
51 vallimmal 60 F AWMI - +  - + + - + + 165 65 1.65 23.89
52 kuthuputin 50 M AWMI + + + - + - + + 165 65 1.65 23.89
53 shanmugavel 61 M AWMI  - - - +  - - + - 163 85 1.85 31.69
54 dhandapni 46 M AWMI + +  - - - - + + 150 56 1.5 24.88
55 lakshmi 60 F AWMI -  + + - + - + + 151 54 1.5 23.68
S.
No.
NAME AGE SEX Diagnosis smoker SHT DM obesity dyslipidemia
family
history
thrombolysis inotropic Height Weight BSA BMI
56 jamaluddin 61 M AWMI  - - + - + - + - 163 60 1.6 22.64
57 kahanbri 60 F AWMI - + - + - - + - 163 84 1.85 31.69
58 velu 41 M AWMI  - - - - + + + + 175 85 2 28.33
59 ponnusamy 72 M IWMI + +  - -  - - + - 168 65 1.7 23.04
60 keshvan 64 M AWMI - +  + - - - + - 161 72 1.75 24.91
61 anif 54 M IWMI  - - - - - - + + 170 90 1.95 31.14
62 kaushalya 55 F AWMI -  + + - + - + + 163 65 1.7 24.52
63 narayannan 65 M IWMI  - + + - + - + - 163 75 1.75 28.3
64 ravichandran 50 M AWMI + - - - + - + - 166 74 1.8 26.9
65 dhanalakshmi 65 F AWMI - + + + + - + + 163 85 1.85 31.69
66 ravi 52 M IWMI + +  + + + - + - 173 57 1.7 19.06
67 chellatai 75 F AWMI -  + + - + - + + 165 75 1.8 27.57
68 shakuntala 70 F AWMI - - - - + - + - 150 60 1.5 26.66
69 shankar 46 M IWMI + - - - - - + - 162 67 1.7 25.57
70 prabhavati 51 F IWMI -   - - - - - + - 170 49 1.45 16.95
71 xavier francis 42 M AWMI + - - - - - + - 163 84 1.85 31.69
72 abdulla 48 M AWMI  - + - - - - + - 163 75 1.75 28.3
73 kolandi mary 75 F IWMI - - - - - - + - 155 65 1.65 27.08
74 anbu 43 M AWMI + - + - + - + - 168 65 1.7 23.04
75 mukundan 59 M AWMI  - - - - - - + - 150 50 1.4 22.22
76 shanta 58 F AWMI - + - - + - + - 165 70 1.75 25.73
77 meena 35 F AWMI - - - - - - + - 165 90 1.95 33.08
78 rafiq 59 M AWMI  -  -  + + + - + - 170 85 1.95 29.41
79 ponram 68 M IWMI + +  + - + - + - 173 57 1.7 19.06
80 emanuvel 32 M AWMI + - - - - - + - 156 63 1.75 30.04
81 jesudoss 71 M AWMI + + + - + - + - 170 89 2 30.79
82 sesammal 60 F AWMI -  +  + - + - + + 165 73 1.75 26.83
83 george 51 M AWMI - - + - + - + - 172 64 1.65 21.69
84 fathima 70 F AWMI - + + + + - + - 165 90 1.95 33.08
S.
No.
NAME AGE SEX Diagnosis smoker SHT DM obesity dyslipidemia
family
history
thrombolysis inotropic Height Weight BSA BMI
85 sundarbabu 60 M AWMI  - -  - - - - + - 160 60 1.6 23.43
86 vallimmal 59 F IWMI - +  + + + - + - 156 50 1.45 19.76
87 damayendi 55 F AWMI  + + - - + - + - 170 72 1.8 24.91
88 dhanalakshmi 65 F AWMI -  +  + - - - + + 165 70 1.77 25.7
89 murugan 50 M AWMI +  -  + - + - + + 167 70 1.79 25.1
90 venkatesan 55 M IWMI  - - - - - - + - 160 70 1.7 27.34
91 chandra 65 F AWMI - + + - + - + + 155 55 1.53 22.9
92 shakuntala 70 F IWMI - + - -  - - + - 150 50 1.4 22.22
93 vishalkshi 70 F AWMI - + - - + - + + 168 85 1.95 29.41
94 arokydass 40 M IWMI + - - - - - + - 163 65 1.7 24.52
95 rajendran 54 M AWMI + - + - + - + + 155 68 1.7 25
96 ellappan 40 M IWMI + - - - - - + - 170 70 1.75 24.22
97 sarvanan 43 M AWMI - - - - - - + - 170 85 1.95 29.82
98 srinivasan 42 M IWMI +  +  + -  + - + - 163 75 1.75 28.3
99 sundari 56 F IWMI - +  + - + - + - 168 49 1.45 16.95
100 nahour miran 60 M AWMI - + + - + - + - 175 85 2 28.33
101 mani 39 M AWMI + - - - - - + - 151 54 1.5 23.68
102 jarrish 65 M AWMI  - + + - + - + + 161 72 1.75 24.91
103 subramaniyan 57 M AWMI  - + - - + - + - 170 85 1.95 29.82
104 santhanm 48 M IWMI - - - - - + + - 173 64 1.6 21.4
105 kairunisaa 47 F IWMI - -  - - + - + - 169 57 1.7 19.06
106 annamalia 62 M IWMI - - + - - - + - 163 65 1.7 24.52
107 arumugam 47 M IWMI + -  - - + - + - 166 74 1.8 26.9
108 salim 55 M AWMI + - + - + - + - 172 64 1.65 21.69
109 kumayangani 48 M AWMI + - - -  - - + - 176 72 1.85 23.3
110 sulochana 57 F AWMI  + + + -  + - + + 151 54 1.5 23.68
S.
No. Killip CPK CXR EF LVIDd LVIDs WMSI DD e/e' LAV LAVI MR Re MI arrthytmia LV Dysf VSR DEATH
1 1 raised - 55 43 23 1.35 1 9.23 24 14.11 - - - - - -
2 2 raised congestion 35 42 29 1.64 1 6.75 30.19 18.86 trivial - - + - -
3 2 raised congestion 30 47 37 1.41 2 12.78 58.3 32.38 trivial - + + - -
4 1 raised - 50 43 28 1.11 0 4.25 48.6 24.3 - - - + - -
5 1 raised - 45 43 26 1.35 1 9.47 30.2 18.87 trivial - - + - -
6 1 raised - 35 44 27 1.35 1 9.87 45.6 24 - - - + - -
7 1 raised - 46 42 30 1.29 1 7.97 34 17.43 - - - + - -
8 3 raised congestion 30 43 32 1.7 1 5.57 33.2 17.02 trivial - - + - -
9 2 raised congestion 30 43 32 1.7 3 13.17 54.55 32.08 trivial - + + - +
10 3 raised congestion 45 40 25 1.58 2 11.2 48.09 32.06 mod - - + - -
11 2 raised congestion 40 38 29 1.52 2 14.34 20 13.46 - - - + - -
12 2 raised congestion 35 43 26 1.52 1 9.8 31.4 16.1 - - - + - -
13 2 raised congestion 40 42 36 1.29 1 9.45 30.2 18.3 - - + + - -
14 2 raised congestion 35 44 29 1.41 2 11.63 63.2 32.41 trivial - + + - -
15 1 raised - 45 37 24 1.3 1 5.17 61.01 32.97 - - - + - -
16 2 raised congestion 45 48 28 1.35 2 15.2 57.69 32.05 mild + - + + -
17 1 raised  - 30 45 30 1.64 1 6.04 24.1 14.17 - - - + - -
18 1 raised  - 45 46 35 1.29 2 13.5 24.2 14.23 - - - + - -
19 2 raised congestion 30 41 28 1.47 2 10.65 32.1 16.89 trivial - - + - -
20 3 raised congestion 35 48 36 1.47 2 13.06 31.1 15.94 - - + + - -
21 2 raised congestion 30 49 36 1.64 2 11.34 56.04 32.02 trivial + - + - -
22 3 raised congestion 45 43 30 1.35 2 16.2 59.23 32.01 trivial - - + - -
23 3 raised congestion 30 43 31 1.58 1 8.78 54.3 32.9 mild - + + - +
24 2 raised congestion 30 41 36 1.64 2 11.9 52.9 32.06 mild - + + - -
25 1 raised  - 50 40 23 1.11 0 7.7 28.7 16.88 - - - - - -
26 3 raised congestion 45 44 31 1.3 2 10.02 52.9 32.06 trivial + - - - -
27 1 raised  - 55 49 29 1.1 0 8.8 38.79 19.39 - - - - - -
S.
No. Killip CPK CXR EF LVIDd LVIDs WMSI DD e/e' LAV LAVI MR Re MI arrthytmia LV Dysf VSR DEATH
28 1 raised  - 40 39 27 1.35 1 6.49 22.3 12.05 mild - - + - -
29 3 raised congestion 30 50 40 1.7 3 17.1 48.09 32.06 mod - + + - +
30 1 raised  - 45 37 24 1.23 1 5.17 28.7 15.51 - - + + - -
31 1 raised  - 65 34 16 1.1 0 6.4 36.4 18.66 - - - - - -
32 3 raised congestion 35 48 39 1.47 3 15.6 29.23 17.71 mild - + + - -
33 1 raised  - 55 49 29 1.23 0 8.3 28.89 17.5 - - - - - -
34 3 raised congestion 30 43 31 1.6 1 8.76 53.6 32.48 mild - + + + +
35 2 raised congestion 30 50 40 1.7 3 16.2 48.01 32.6 mod - + + - -
36 1 raised  - 50 46 32 1.29 0 8.9 28 16 - - - - - -
37 1 raised  - 41 41 26 1.35 2 13.2 32 18.34 - - - + - -
38 1 raised  - 50 46 32 1.29 0 8.9 28.2 16.58 - - - - - -
39 1 raised  - 45 47 31 1.29 1 5 30.01 17.14 - - - + - -
40 2 raised congestion 30 46 32 1.6 3 14.5 15.75 32.08 - - + + - -
41 1 raised  - 50 52 30 1.29 0 4.6 25.6 14.2 - - - - - -
42 3 raised congestion 45 40 25 1.58 1 11.45 48.02 32.01 - + - + - -
43 1 raised  - 50 45 28 1.23 0 6.5 28.7 16.88 - - - - - -
44 3 raised congestion 35 45 29 1.64 2 16.02 57.62 32.01 trivial - + + - -
45 1 raised  - 50 43 28 1.11 0 4.25 38.9 19.45 - - - - - -
46 2 raised congestion 30 49 36 1.7 2 13.78 56.1 32.05 trivial - + + + -
47 1 raised  - 65 34 16 1.23 0 6.4 36.4 18.66 - - - - - -
48 2 raised congestion 40 48 38 1.29 1 4.76 28.9 14.82 - - - + - -
49 3 raised congestion 28 50 45 1.87 3 13.75 52.267 36.8 mild - + + - +
50 2 raised congestion 45 43 26 1.35 1 9.47 30.1 18.81 trivial - - - - -
51 3 raised congestion 40 42 36 1.36 1 6.56 23.1 14 - - + + - -
52 2 raised congestion 40 41 30 1.35 2 11.4 52.91 32.06 trivial + + + + -
53 1 raised  - 50 39 28 1.3 2 12.56 29.4 15.89 - - - - - -
54 3 raised congestion 35 44 32 1.47 2 12.89 24.6 16.4 - - - + - -
55 2 raised congestion 35 48 35 1.47 2 14.02 48.07 32.04 - - + + - -
S.
No. Killip CPK CXR EF LVIDd LVIDs WMSI DD e/e' LAV LAVI MR Re MI arrthytmia LV Dysf VSR DEATH
56 2 raised congestion 35 44 31 1.47 1 7.54 24.5 15.31 - - - + - -
57 1 raised  - 40 39 27 1.35 1 6.44 26.4 14.27 - - - + - -
58 2 raised congestion 40 48 38 1.47 1 4.76 38.7 19.35 trivial - + + - -
59 1 raised  - 41 41 26 1.35 2 13.2 29.89 17.58 trivial - - + - -
60 1 raised  - 50 39 28 1.2 2 12.56 25 14.28 - - - - - -
61 2 raised congestion 35 38 36 1.41 2 13.06 26 13.33 trivial - + + - -
62 2 raised congestion 30 33 24 1.6 2 10.8 54.67 32.15 trivial - + + - -
63 1 raised  - 45 47 30 1.23 1 9.8 29.8 17.02 mild - + + - -
64 1 raised  - 30 47 37 1.49 2 12.78 22.3 12.3 - - + + - -
65 2 raised congestion 50 39 28 1.3 2 6.44 32 17.29 - - - - - -
66 2 raised congestion 50 40 23 1.11 0 10.09 54.45 32.02 - - + - - -
67 3 raised congestion 35 45 29 1.64 2 15.09 57.75 32.08 - - + + - +
68 2 raised congestion 40 42 25 1.35 1 8.82 24.6 16.4 - - + + - -
69 1 raised  - 50 52 30 1.29 0 4.66 54.9 32.29 mild - - - - -
70 2 raised congestion 45 44 28 1.29 2 9.62 27.89 19.23 mod + - + - -
71 3 raised congestion 35 44 32 1.64 2 12.89 29 15.67 - - - + - -
72 1 raised  - 45 37 24 1.23 1 5.17 27 15.42 - - - + - -
73 3 raised congestion 40 42 36 1.35 1 9.45 26.9 16.3 mild - + + - -
74 1 raised  - 55 43 24 1.35 0 7.6 25.1 14.76 - - - - - -
75 1 raised  - 45 35 25 1.11 1 8 23.1 16.5 trivial - - + - -
76 3 raised congestion 35 45 39 1.49 3 15.6 24.5 14 trivial - + + - -
77 2 raised congestion 35 43 26 1.52 1 9.8 31.4 16.1 - - - + - -
78 2 raised congestion 40 48 38 1.47 1 4.76 28.4 14.56 trivial - - + - -
79 1 raised  - 50 40 23 1.11 0 10.7 54.5 32.05 - - + - - -
80 3 raised congestion 45 46 28 1.41 1 15.9 56.01 32 trivial - + + - -
81 2 raised congestion 35 48 36 1.47 2 11.2 64.25 32.25 - + + + - -
82 3 raised congestion 25 64 59 1.64 3 15.2 56.13 32.07 trivial + + + - -
83 1 raised  - 40 38 26 1.27 1 6.71 28.5 17.27 - - - + - -
S.
No. Killip CPK CXR EF LVIDd LVIDs WMSI DD e/e' LAV LAVI MR Re MI arrthytmia LV Dysf VSR DEATH
84 2 raised congestion 45 44 28 1.11 1 8 30.14 15.45 - - - + - -
85 2 raised congestion 35 42 29 1.64 1 6.75 23.56 14.72 - - - + - -
86 3 raised congestion 45 41 25 1.3 2 10.2 46.52 32.08 mod + - + - -
87 2 raised congestion 45 48 28 1.35 1 10.21 57.89 32.16 - + - + - -
88 3 raised congestion 35 42 30 1.64 1 9.8 56 32 trivial - + + - +
89 2 raised congestion 35 55 44 1.62 3 18 72.85 41.62 trivial - + + - +
90 1 raised  - 63 44 24 1.11 0 7.07 24.6 14.47 - - - - - -
91 2 raised congestion 38 53 45 1.67 3 22.5 56.52 36.94 mild + - + - +
92 1 raised  - 45 35 25 1.11 1 8 20.01 14.35 - - - + - -
93 3 raised congestion 30 43 32 1.7 1 5.57 29.4 15.07 - - - + - -
94 1 raised  - 50 46 32 1.29 0 8.45 24.1 14.17 trivial - - - - -
95 2 raised congestion 30 45 32 1.64 1 6.04 28.41 16.71 - - + + - -
96 1 raised  - 38 41 30 1.23 1 6.5 26.4 15.08 mild - - + - -
97 1 raised  - 46 42 30 1.29 1 7.97 28.4 14.56 - - - + - -
98 2 raised congestion 45 47 30 1.3 2 9.8 56.16 32.09 trivial - + + - -
99 2 raised congestion 45 44 28 1.3 2 13.2 46.55 32.1 mild - + + - -
100 1 raised  - 55 49 29 1.23 0 8.8 35.67 17.83 - - - - - -
101 2 raised congestion 35 48 35 1.47 1 7.04 32.1 21.4 mod - - + - -
102 1 raised  - 50 39 28 1.3 2 12.56 25 14.28 - - - - - -
103 1 raised  - 46 42 30 1.29 1 7.97 28.4 17.58 - - - + - -
104 2 raised congestion 45 44 26 1.35 1 9.47 31.1 18.81 - - - + - -
105 1 raised - 55 43 20 1.25 0 7.6 25.1 14.76 trivial - - - - -
106 1 raised - 50 46 28 1.29 0 6.8 29.89 17.58 - - - - - -
107 1 raised - 50 52 30 1.11 0 4.66 25.6 14.2 trivial - - - - -
108 1 raised  - 40 38 26 1.37 1 6.71 28.5 17.27 - - - + - -
109 1 raised - 45 37 24 1.39 1 5.17 61.01 32.97 - - - + - -
110 2 raised congestion 35 48 35 1.47 2 14.02 48.07 32.04 trivial - + + - -
